Cholesterol is the obligatory precursor of steroid hormones in the adrenal cortex. The mitochondria1 oxidative cleavage of the sterol side chain to yield pregnenolone and an isohexanoyl fragment is considered to be the initial and possibly rate-limiting event in steroidogenesis in the adrenal cortex. The importance of this cholesterol side-chainVol. 6
cleavage reaction in steroidogenesis in the adrenal cortex was stressed by Stone & Hechter (1954) . This split of the cholesterol molecule between C(20) and C(22) appears to be effected by a mitochondria1 mixed-function oxidase complex, and this enzymic reaction requires oxygen and NADPH. The presence of cytochrome P-450 in adrenalcortex mitochondria was demonstrated by Harding el al. (1964) . In the adrenal-cortex mitochondria there are at least three separate steroid hydroxylase systems containing cytochrome P-450. These are the hydroxylations in the cholesterol side chain leading to the formation of pregnenolone (Simpson &Boyd, 1966) , as well as the 1 lg-hydroxylation reaction (Wilson et al., 1965) and the 18-hydroxylation reaction (Greengard et al., 1967) . Evidence for the participation of cytochrome P-450 in these steroid-hydroxylation reactions has been obtained from studies using carbon monoxide as an inhibitor of the mixed function oxidases and the reversal of this inhibition by light of 450nm. Therefore cytochromeP-450 in adrenal-cortex mitochondria acts as the terminal oxidases in certain hydroxylation events. Omura et af. (1966) resolved the steroid 1 lg-hydroxylase system into three fractions, cytochrome P-450, an FAD flavoprotein and an iron-sulphur protein adrenodoxin (Suzuki & Kimura, 1965) ; the steroid 1 lg-hydroxylase activity could be reconstituted when these three proteins were combined. The cholesterol side-chaincleavage system has been resolved into similar components (Simpson & Boyd, 1967; Bryson & Sweat, 1968) as has the steroid 18-hydroxylase (Nakamura et al., 1969) .
Limited amounts of cholesterol are available within adrenal mitochondria for use as the substrate in the sterol side-chain-cleavage reaction. This is shown by the kinetics of mitochondria1 pregnenolone formation and by the optical and e.p.r. spectra of mitochondria1 cytochrome P-45OsCc (Simpson & Boyd, 1971 ) . If corticotropin ('ACTH') is administered to a rat or if the animal is subjected to ether anaesthesia, which elevates the plasma corticotropin concentration, a few minutes before removal of the adrenals, the adrenal-cortex mitochondrial cholesterol side-chain-cleavage reaction is affected.
Elevation of the plasma corticotropin concentration increases the proportion of cholesterol in the mitochondria bound to cytochrome P-450scc in a high-spin complex (Jefcoate et al., 1973) . Cycloheximide administration to rats tends to block the effects of subsequent corticotropin administration and decreases pregnenolone production by adrenal-cortex mitochondria. However, cycloheximide does not prevent the mitochondrial accumulation of cholesterol induced by corticotropin (Mahaffee et al., Arthur etal., 1976) . Thissuggests that the corticotropin-induced activation of cholesterol ester hydrolase (Boyd & Trzeciak, 1973) and the transport of free cholesterol to mitochondria is not limited by prior administration of cycloheximide. The cycloheximidesensitive factor or labile protein factor (Garren et al., 1965) may act on intramitochondrial cholesterol movement. Jefcoate et al. (1974) implied that the cycloheximidesensitive process was dependent on the nature of the sterol substrate, since the adrenal metabolism of 25-hydroxycholesterol was insensitive to the action of cycloheximide. Mason et al. (1978) showed that analogues of cholesterol, desmosterol, 26-norcholest-5-en-3j?-ol and 5-cholen-3~-01 with non-polar alkyl side chains like cholesterol were sensitive to cycloheximide pretreatment, whereas the metabolism of analogues of cholesterol with polar side chains such as 20a-, 24-, 25-and 26-hydroxycholestero1 were insensitive to cycloheximide pretreatment. This imp1 ies that the cycloheximide-sensitive process in sterol metabolism appeared to be related to the transfer of non-polar sterols such as cholesterol within the mitochondria.
Cytochrome P-450 has been partially purified to a specific content of 8-IOnmollmg of protein, as a substrate-depleted low-spin form.
The individual events in the catalytic cycle of cytochrome P-450scc have been investigated and are consistent with the scheme proposed by Gunsalus et al. (1972) and Estabrook et al. (1972) for a single turnover of cytochrome P-45OCAM. In the present investigation the observable spectral perturbation on addition of cholesterol to the lowspin cytochrome P-450scc preparation is a decrease in A416 and Aass and an increase in A392 and A648nm. This has been interpreted as a low-to high-spin state change as shown in Fig. 1 , and an equilibrium constant has been calculated (&. = 0.43f0.031~) for the association of cholesterol with cytochrome P-450scc. Wavelength (nm) Fig. 1 . Absolute spectral changes at equilibrium on addition of cholesterol to low-spin cytochrome P-450scc
Cholesterol stock solution ( 2 m~ in propylene glycol) was added to a 1 ml spectrophotometer cuvette containing low-spin cytochrome P-45OScc. The cytochrome P-45OScc concentration was 17.2nmol/ml in 10mM-potassium phosphate buffer, pH7.4, with ImM-EDTA and spectra were recorded after incubation for 15h at 20°C. The concentrationsof added cholesterol were: 1, OM; 2,5pM; 3,13.8p~; 4,17pM; 5 , 5 0 p~.
The rate of cholesterol association with cytochrome P-45&cc in intact mitochondria appears to be rate-limiting for the side-chain cleavage of cholesterol. Similar observations made with partially purified cytochrome P-450scc show that the first-order rate constant for cholesterol association is 7.4 x lob's-' in 10m-potassium phosphate buffer, pH 7.4, at 20°C. A first-order constant of the same order can be observed in intact rat adrenal mitochondria (Mason et al., 1978) .
The second step in the catalytic cycle is the reduction of the cytochrome P-45&cc-cholesterol complex. This first reduction reaction appears to be non-specific with respect to the electron donor. The cytochrome P-450x+holesterol complex has been established as an acceptor of one electron per haem group. This agrees with previous observations on cytochrome P-45OCAM (Gunsalus et a[., 1972; Peterson et a/., 1972) and with liver microsomal cytochrome P-450 (Peterson et al., 1977; Cooper et al., 1977) .
The third step in the catalytic cycle is the oxygenation of ferrous cytochrome P-450sc~holesterol complex with the development of a spectrum having a Soret maximum at 418 nm. This spectral species is considered to be an oxygenated cytochrome P-450 similar to that described for oxygenated cytochrome P-450cAM (Gunsalus et al., Estabrook et al., 1972; . The oxygenated species decays exponentially with time to ferric cytochrome P-4505cc (see Fig. 2 ). This autoxidation is first-order (k=O.Ols-' at 4°C) with an activation energy of 76kJ (18kcal)/mol. In the absence of adrenodoxin the autoxidation of the oxygenated cytochrome P-45&cc-sterol complex occurs without hydroxylation of cholesterol. Addition of adrenodoxin to the oxygenated cytochrome P-450sc~holesterol complex results in hydroxylation of cholesterol. These observations suggest that the adrenodoxin not only is an electron donor to cytochrome P-450, but acts as an effector in the formation of hydroxylated sterol. This evidence concerning the reaction sequence by which cytochrome P-45GCc interacts with substrate, oxygen and electron donors is consistent with the basic cyclic scheme proposed by Estabrook et al. (1972) . However, this scheme was established for cytochrome P-450 reactions in which the end product of the sequence was a monohydroxylated product. In the present studies the hydroxylation of Vol. 6 (Shimizu et al., 1961) . Chaudhuri et al. (1962) showed that (22R)-22-hydroxycholesterol was converted into pregnenolone. Burstein et al. (1970) , by a kinetic approach using radioactive sterols and an acetone-dried-powder preparation of bovine adrenal mitochondria concluded that the formation of (20S)-20-hydroxycholesterol from cholesterol is a slower reaction than that involving the production of (22R)-22-hydroxychoIesterol; they also concluded that the rate of (22R)-22-hydroxycholesterol utilization for pregnenolone synthesis was greater than the rate of utilization of (20S) Hochberg et al. (1974) consider that the hydroxylated cholesterol compounds may be by-products of the side-chain cleavage of cholesterol and that the true intermediates are short-lived reactive complexes involving steroid, oxygen and a metalloenzyme.
Methods were developed for the detection of intermediates in the side-chain cleavage of cholesterol. Cytochrome P-450scc can be depleted of its substrate No. of reductiodoxygenation cycles cholesterol; this allows addition of [14CJcholesterol of known specific radioactivity to the enzyme. The oxidized cytochrome P-450scc-cholesterol is a one-electron acceptor that can be reduced by stoicheiometric amounts of sodium dithionite under anaerobic conditions. Reduced cytochrome P-450scc~holesterol can be oxygenated and then reduced stoicheiometrically with adrenodoxin. This iron-sulphur protein is a one-electron donor (Estabrook et al., 1972) and is required both as an electron donor and as an effector molecule for the reduction of the oxygenated cytochrome P-450scc-cholesterol complex. These steps allow single turnover cycles to be studied. When such experiments are performed and the incubated contents extracted and t.1.c. of the extracts is performed (Simpson & Boyd, 1967) , a major product (A) had an R F value between that of cholesterol and pregnenolone. Trace amounts of pregnenolone and a product (B), which had an R F value less than that of pregnenolone, were also detected. If the anaerobic stoicheiometric reduction of cytochrome P-450scc-cholesterol-adrenodoxin complex is repeated for a second time the pattern of products changes. The cycle can be repeated many times and Fig. 3 shows such an experiment containing seven cycles. Expressing the products as a percentage conversion of the total cholesterol added to the incubation, a pattern emerged suggesting that the product-precursor relationship was of the type, cholesterol -+ product A + product B pregnenolone. Product A was extracted from a t.1.c. plate, added to a low-spin substrate-depleted cytochromeP-450,cc preparation and a single-cycle turnover experiment performed; the reaction product was shown to be product B. Similarly, when product B was isolated from such an experiment and added to a low-spin substrate-depleted cytochrome P-450scc preparation and a single-cycle turnover experiment performed, the reaction product was shown to be pregnenolone.
Identification of product A and product B by t.l.c., g.1.c. and g.l.c./mass spectrometry of the trimethylsilyl derivatives and comparison of the g.l.c./mass-spectrometric trace with known standards have been performed. Product A has been identified as 22-hydroxycholestero1 and product B has been identified as 20,22-dihydroxycholesterol. No other products were detected. The sequence of side-chain cleavage determined by
